Strides Arcolab Ltd (STAR.BO)
29 Jan 2015
MUMBAI - Strides Arcolab Ltd has agreed to buy smaller rival Shasun Pharmaceuticals Ltd in an all-stock deal, valued at about $200 million, to bolster its generic medicine and drug ingredient businesses.
* Deal valued at about $200 mln based on Friday closing price
MUMBAI, Sept 29 - Indian generic drugmaker Strides Arcolab Ltd said on Monday it had agreed to merge with smaller peer Shasun Pharmaceuticals Ltd in an all-stock deal.